Bosl GJ - Search Results

1

Chemotherapy as part of the initial treatment for nasopharyngeal cancer.

Harrison LB, Pfister DG, Bosl GJ. Harrison LB, et al. Among authors: bosl gj. Oncology (Williston Park). 1991 Feb;5(2):67-70;discussion 70-1,74,79 passim. Oncology (Williston Park). 1991. PMID: 1826210 Review.

2

High-dose chemotherapy for resistant germ cell tumors: recent advances and future directions.

Motzer RJ, Bosl GJ. Motzer RJ, et al. Among authors: bosl gj. J Natl Cancer Inst. 1992 Nov 18;84(22):1703-9. doi: 10.1093/jnci/84.22.1703. J Natl Cancer Inst. 1992. PMID: 1331482 Review.

3

Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.

Motzer RJ, Bajorin DF, Vlamis V, Weisen S, Bosl GJ. Motzer RJ, et al. Among authors: bosl gj. Semin Oncol. 1992 Dec;19(6 Suppl 12):8-11. Semin Oncol. 1992. PMID: 1336624

4

Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors.

Bajorin DF, Herr H, Motzer RJ, Bosl GJ. Bajorin DF, et al. Among authors: bosl gj. Semin Oncol. 1992 Apr;19(2):148-58. Semin Oncol. 1992. PMID: 1372757 Review.

5

Current status of larynx preservation with multimodality therapy.

Pfister DG, Harrison LB, Strong EW, Bosl GJ. Pfister DG, et al. Among authors: bosl gj. Oncology (Williston Park). 1992 Mar;6(3):33-8, 43; discussion 44, 47. Oncology (Williston Park). 1992. PMID: 1533144

6

Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).

Motzer RJ, Geller NL, Tan CC, Herr H, Morse M, Fair W, Sheinfeld J, Sogani P, Russo P, Bosl GJ. Motzer RJ, et al. Among authors: bosl gj. Cancer. 1991 Mar 1;67(5):1305-10. doi: 10.1002/1097-0142(19910301)67:5<1305::aid-cncr2820670506>3.0.co;2-j. Cancer. 1991. PMID: 1703917 Clinical Trial.

7

BOMM: new solution or old problem?

Pfister DG, Bosl GJ. Pfister DG, et al. Among authors: bosl gj. Cancer Invest. 1991;9(5):605-6. doi: 10.3109/07357909109018960. Cancer Invest. 1991. PMID: 1718578 No abstract available.

8

Two-drug therapy in patients with metastatic germ cell tumors.

Bajorin DF, Geller NL, Weisen SF, Bosl GJ. Bajorin DF, et al. Among authors: bosl gj. Cancer. 1991 Jan 1;67(1):28-32. doi: 10.1002/1097-0142(19910101)67:1<28::aid-cncr2820670106>3.0.co;2-3. Cancer. 1991. PMID: 1845937 Clinical Trial.

9

Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies.

Motzer RJ, Rodriguez E, Reuter VE, Samaniego F, Dmitrovsky E, Bajorin DF, Pfister DG, Parsa NZ, Chaganti RS, Bosl GJ. Motzer RJ, et al. Among authors: bosl gj. J Natl Cancer Inst. 1991 Mar 6;83(5):341-6. doi: 10.1093/jnci/83.5.341. J Natl Cancer Inst. 1991. PMID: 1847433

10

Chemotherapy and the management of locally advanced squamous cell carcinoma of the head and neck: role in larynx preservation.

Bosl GJ, Strong E, Harrison L, Pfister DG. Bosl GJ, et al. Important Adv Oncol. 1991:191-203. Important Adv Oncol. 1991. PMID: 1869277 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters